The role of typical and atypical pathogens in acute exacerbations of chronic obstructive pulmonary disease

Sevilay Yildiz1, Nevriye Gonullu1, Birsen Pinar Yildiz2

  • 1Department of Microbiology and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Abstract

Insights

Detecting multiple pathogens, including Haemophilus influenzae and Streptococcus pneumoniae, improves identification of acute exacerbations of chronic obstructive pulmonary disease (COPD). Advanced methods like PCR and DFA are crucial for diagnosing Legionella and Pseudomonas aeruginosa in severe COPD cases.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Chronic obstructive pulmonary disease (COPD) exacerbations are often linked to infections, but the specific roles of atypical pathogens like Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila are not fully understood.
  • Identifying causative agents is crucial for effective treatment and management of COPD exacerbations.

Purpose of the Study:

  • To identify nonspecific and atypical pathogens associated with acute exacerbations of COPD.
  • To evaluate the diagnostic yield of combining culture methods with advanced techniques like PCR and DFA.

Main Methods:

  • Analysis of 107 patients (69 inpatient, 38 outpatient) between February 2013 and February 2015.
  • Utilized nonspecific culture, polymerase chain reaction (PCR), and direct fluorescent antibody (DFA) tests for pathogen detection.
  • Investigated the association of specific pathogens with patient characteristics and treatment modalities.

Main Results:

  • The combination of PCR, DFA, and culture methods increased pathogen detection from 46.7% to 85.1%.
  • Multiple causative agents were identified in 53.3% of exacerbations.
  • Haemophilus influenzae (58.9%) and Streptococcus pneumoniae (53.2%) were most common; Legionella pneumophila (10%) was more frequent in inpatients.
  • Pseudomonas aeruginosa was associated with continuous oxygen therapy and noninvasive mechanical ventilation (NIV).

Conclusions:

  • Multiplex PCR and DFA significantly enhance the identification of infectious agents in acute COPD exacerbations.
  • High suspicion for Pseudomonas aeruginosa is warranted in patients on oxygen or NIV.
  • Legionella pneumophila should be considered in severe COPD exacerbations.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K